Orbit Posts $761K Q3 Loss as Contract Delays Push Key Awards to 2027
ORBT is trading near its 52-week low of $2.38 (7.6% above the low).
Summary
Orbit reported a Q3 2026 net loss of $761,000 ($0.20 per share), narrower than the $875,000 ($0.26) loss a year earlier, but adjusted EBITDA worsened to a $627,000 loss from $508,000. Sales rose to $6,159,000 from $5,785,000 while gross margin fell to 28.7% from 31.9%. The bigger issue is timing: roughly $6 million of follow-on awards from Orbit Instrument's two largest customers, previously expected during 2026, have slipped to the first half of 2027, and the DAGR replacement opportunity is not expected before the second half of 2027. Backlog of $14.9 million is up from $12.3 million at year-end and the highest since September 2024, with OPG bookings up 42.9% through October and VPX power supply bookings above $5 million for the first time. Liquidity was shored up by a new $6 million credit facility and a $4,075,000 private placement of 1,630,000 shares at $2.50, leaving $912,000 of cash against $2,576,000 drawn on the line.
At the time of this announcement, ORBT was trading at $2.56 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $9M. The 52-week trading range was $2.38 to $13.57. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.